Artificial intelligence is poised to dramatically reshape the process of developing and approving new medicines, according to ...
The Costs They Are a-Rising: Commercialization Costs and the Innovation Process in Drug Development.
Khoshsokhan, Sina. The Costs They Are a-Rising: Commercialization Costs and the Innovation Process in Drug Development. Academy of Management Annual Meeting Proceedings. 2024, Vol. 2024 Issue 1, p1-6.
Pharmaceutical manufacturing is the industrial-scale process of producing medications through chemical synthesis, biotechnology, or extraction, ensuring both quality and regulatory compliance.
“The idea to process drugs in space isn’t new. Research showing that microgravity can impact crystallization has been done on ...
In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain is ...
Backed by a $30 million gift from an anonymous donor, the Center for Advanced Therapeutics will serve as a central resource ...
6don MSN
Some new drugs aren't actually 'new': Pharmaceutical companies exploit patents and raise prices
Pharmaceutical innovation saves lives. But not every "new" drug is truly new.
The various roles for oncology nurses in the conduct of clinical trials were described in a presentation at the 2025 ONS Bridge virtual meeting.
The Costs They Are a-Rising: Commercialization Costs and the Innovation Process in Drug Development.
Commercialization is a crucial phase in the innovation process and its associated costs significantly influence R&D decisions. Yet our understanding of how commercialization costs impact various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback